Replies to post #157261 on Biotech Values

[biomaven0]

>ONXX

8% royalty on global net sales on PD-991 is likely enough to move the needle - I could easily see upward of $1/share in EPS a few years out just from the royalty on this, given it's one of the most exciting new oncology prospects out there.

Peter